| 04/03/15 | 11:54:03 | 4 Mar 2015 | | AZ TO PARTICIPATE IN US FDA EMDAC | RNS |
| 03/03/15 | 07:05:17 | 3 Mar 2015 | | Acquisition of Rights to Actavis' Portfolio | RNS |
| 02/03/15 | 15:00:03 | 2 Mar 2015 | | Total Voting Rights | RNS |
| 17/02/15 | 07:00:17 | 17 Feb 2015 | | Directorate Change | RNS |
| 16/02/15 | 07:00:39 | 16 Feb 2015 | | PULMICORT RESPULES® US PATENT LITIGATION DECISION | RNS |
| 05/02/15 | 07:02:06 | 5 Feb 2015 | | AZ to acquire Actavis' US respiratory portfolio | RNS |
| 05/02/15 | 07:00:22 | 5 Feb 2015 | | Final Results | RNS |
| 04/02/15 | 09:00:03 | 4 Feb 2015 | | Notice of Results | RNS |
| 02/02/15 | 14:00:14 | 2 Feb 2015 | | Total Voting Rights | RNS |
| 22/01/15 | 07:00:19 | 22 Jan 2015 | | MAA FOR GOUT TREATMENT LESINURAD ACCEPTED BY EMA | RNS |
| 14/01/15 | 07:43:59 | 14 Jan 2015 | | BRILINTA PEGASUS STUDY MEETS PRIMARY ENDPOINT | RNS |
| 02/01/15 | 14:00:01 | 2 Jan 2015 | | Total Voting Rights | RNS |
| 19/12/14 | 17:40:26 | 19 Dec 2014 | | LYNPARZA APPROVED BY THE US FDA | RNS |
| 18/12/14 | 07:00:17 | 18 Dec 2014 | | LYNPARZAT APPROVED IN THE EUROPEAN UNION | RNS |
| 09/12/14 | 07:00:36 | 9 Dec 2014 | | MOVENTIG approved in the EU for OIC | RNS |
| 05/12/14 | 17:03:23 | 5 Dec 2014 | | Jury verdict favours AZ in Nexium litigation | RNS |
| 02/12/14 | 07:00:16 | 2 Dec 2014 | | New Drug Application for IRESSA accepted by US FDA | RNS |
| 01/12/14 | 14:00:04 | 1 Dec 2014 | | Blocklisting Interim Review | RNS |
| 01/12/14 | 14:00:04 | 1 Dec 2014 | | Total Voting Rights | RNS |
| 26/11/14 | 07:00:13 | 26 Nov 2014 | | POSITIVE RESULTS FROM BRODALUMAB PHASE III STUDY | RNS |
| 24/11/14 | 16:00:02 | 24 Nov 2014 | | Publication of Final Terms | RNS |
| 24/11/14 | 07:00:14 | 24 Nov 2014 | | DUAKLIR GENUAIR APPROVED IN THE EU FOR COPD | RNS |
| 19/11/14 | 17:00:02 | 19 Nov 2014 | | Launch and Pricing of a ?750m Bond | RNS |
| 18/11/14 | 07:00:43 | 18 Nov 2014 | | AZ strategy on track to deliver growth and value | RNS |
| 17/11/14 | 16:00:02 | 17 Nov 2014 | | Publication of Supplementary Prospectus | RNS |
| 12/11/14 | 07:00:38 | 12 Nov 2014 | | AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS | RNS |
| 10/11/14 | 14:27:13 | 10 Nov 2014 | | Director/PDMR Shareholding | RNS |
| 06/11/14 | 07:04:01 | 6 Nov 2014 | | ASTRAZENECA TO DIVEST MYALEPT TO AEGERION | RNS |
| 06/11/14 | 07:00:19 | 6 Nov 2014 | | 3rd Quarter Results | RNS |
| 06/11/14 | 07:00:18 | 6 Nov 2014 | | 3rd Quarter Results | RNS |
| 05/11/14 | 07:00:33 | 5 Nov 2014 | | Notice of Results | RNS |
| 04/11/14 | 07:00:28 | 4 Nov 2014 | | MEDIMMUNE ACQUIRES DEFINIENS | RNS |
| 03/11/14 | 15:00:02 | 3 Nov 2014 | | Total Voting Rights | RNS |
| 03/11/14 | 07:00:11 | 3 Nov 2014 | | AZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL | RNS |
| 30/10/14 | 07:00:14 | 30 Oct 2014 | | US FDA APPROVES ONCE-DAILY XIGDUOT XR TABLETS | RNS |
| 24/10/14 | 13:10:31 | 24 Oct 2014 | | Olaparib receives positive CHMP opinion | RNS |
| 02/10/14 | 16:30:09 | 2 Oct 2014 | | Director/PDMR Shareholding | RNS |
| 01/10/14 | 17:00:04 | 1 Oct 2014 | | Total Voting Rights | RNS |
| 29/09/14 | 08:00:18 | 29 Sept 2014 | | ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ESMO | RNS |
| 26/09/14 | 12:15:45 | 26 Sept 2014 | | Positive CHMP Opinion for MOVENTIG (naloxegol) | RNS |
| 16/09/14 | 17:27:36 | 16 Sept 2014 | | FDA Approves MOVANTIK (naloxegol) Tablets | RNS |
| 16/09/14 | 08:00:17 | 16 Sept 2014 | | AZ AND LILLY ALLIANCE TO DEVELOP BACE INHIBITOR | RNS |
| 10/09/14 | 17:30:01 | 10 Sept 2014 | | Director/PDMR Shareholding | RNS |
| 01/09/14 | 17:00:04 | 1 Sept 2014 | | Total Voting Rights | RNS |
| 19/08/14 | 08:00:14 | 19 Aug 2014 | | US DOJ Closes Investigation into Plato | RNS |
| 19/08/14 | 08:00:13 | 19 Aug 2014 | | CAZ-AVI PHASE III RESULTS | RNS |
| 14/08/14 | 08:00:09 | 14 Aug 2014 | | TRALOKINUMAB PHASE III START IN SEVERE ASTHMA | RNS |
| 13/08/14 | 08:00:10 | 13 Aug 2014 | | PHASE III RESULTS LESINURAD COMBINATION THERAPY | RNS |
| 04/08/14 | 14:00:02 | 4 Aug 2014 | | Director/PDMR Shareholding | RNS |
| 01/08/14 | 15:00:02 | 1 Aug 2014 | | Total Voting Rights | RNS |
